Primary biliary cirrhosis

被引:302
作者
Talwalkar, JA [1 ]
Lindor, KD [1 ]
机构
[1] Mayo Clin & Mayo Fdn, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
关键词
D O I
10.1016/S0140-6736(03)13808-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Primary biliary cirrhosis is a chronic cholestatic liver disease of adults. This disorder is characterised histologically by chronic non-suppurative destruction of interlobular bile ducts leading to advanced fibrosis, cirrhosis, and liver failure. The precise aetiopathogenesis of primary biliary cirrhosis remains unknown, although dysregulation of the immune system and genetic susceptibility both seem to be important. Affected patients are typically middle-aged women with abnormal serum concentrations of alkaline phosphatase. Presence of antimitochondrial antibody in serum is almost diagnostic of the disorder. Identification of primary biliary cirrhosis is important, because effective treatment with ursodeoxycholic acid has been shown to halt disease progression and improve survival without need for liver transplantation. However, therapeutic options for disease-related complications-including fatigue and metabolic bone disease-remain unavailable. Mathematical models have been developed that accurately predict the natural history of primary biliary cirrhosis in individuals. Despite advances in understanding of the disease, it remains one of the major indications for liver transplantation worldwide.
引用
收藏
页码:53 / 61
页数:9
相关论文
共 140 条
[71]   Ursodeoxycholic acid delays the onset of esophageal varices in primary biliary cirrhosis [J].
Lindor, KD ;
Jorgensen, RA ;
Therneau, TM ;
Malinchoc, M ;
Dickson, ER .
MAYO CLINIC PROCEEDINGS, 1997, 72 (12) :1137-1140
[72]  
LINDOR KD, 1995, HEPATOLOGY, V22, P1158
[73]   URSODEOXYCHOLIC ACID IN THE TREATMENT OF PRIMARY BILIARY-CIRRHOSIS [J].
LINDOR, KD ;
DICKSON, ER ;
BALDUS, WP ;
JORGENSEN, RA ;
LUDWIG, J ;
MURTAUGH, PA ;
HARRISON, JM ;
WIESNER, RH ;
ANDERSON, ML ;
LANGE, SM ;
LESAGE, G ;
ROSSI, SS ;
HOFMANN, AF .
GASTROENTEROLOGY, 1994, 106 (05) :1284-1290
[74]   CYCLOSPORINE-A TREATMENT IN PRIMARY BILIARY-CIRRHOSIS - RESULTS OF A LONG-TERM PLACEBO CONTROLLED TRIAL [J].
LOMBARD, M ;
PORTMANN, B ;
NEUBERGER, J ;
WILLIAMS, R ;
TYGSTRUP, N ;
RANEK, L ;
RINGLARSEN, H ;
RODES, J ;
NAVASA, M ;
TREPO, C ;
PAPE, G ;
SCHOU, G ;
BADSBERG, JH ;
ANDERSEN, PK .
GASTROENTEROLOGY, 1993, 104 (02) :519-526
[75]   Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: Connecting xenobiotics with primary biliary cirrhosis [J].
Long, SA ;
Quan, C ;
de Water, JV ;
Nantz, MH ;
Kurth, MJ ;
Barsky, D ;
Colvin, ME ;
Lam, KS ;
Coppel, RL ;
Ansari, A ;
Gershwin, ME .
JOURNAL OF IMMUNOLOGY, 2001, 167 (05) :2956-2963
[76]   Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis [J].
Longo, M ;
Crosignani, A ;
Battezzati, PM ;
Giussani, CS ;
Invernizzi, P ;
Zuin, M ;
Podda, M .
GUT, 2002, 51 (02) :265-269
[77]   CANCER RISK IN PRIMARY BILIARY-CIRRHOSIS - A POPULATION-BASED STUDY FROM SWEDEN [J].
LOOF, L ;
ADAMI, HO ;
SPAREN, P ;
DANIELSSON, A ;
ERIKSSON, LS ;
HULTCRANTZ, R ;
LINDGREN, S ;
OLSSON, R ;
PRYTZ, H ;
RYDEN, BO ;
SANDBERGGERTZEN, H ;
WALLERSTEDT, S .
HEPATOLOGY, 1994, 20 (01) :101-104
[78]   The pathology of primary biliary cirrhosis and autoimmune cholangitis [J].
Ludwig, J .
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2000, 14 (04) :601-613
[79]   STAGING OF CHRONIC NONSUPPURATIVE DESTRUCTIVE CHOLANGITIS (SYNDROME OF PRIMARY BILIARY-CIRRHOSIS) [J].
LUDWIG, J ;
DICKSON, ER ;
MCDONALD, GSA .
VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1978, 379 (02) :103-112
[80]   Primary biliary cirrhosis: new thoughts on pathophysiology and treatment. [J].
Mason A. ;
Nair S. .
Current Gastroenterology Reports, 2002, 4 (1) :45-51